← SynDRA
YO.01027
SynDRA canonical compound SYN1970763 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Mechanism of action | gamma secretase inhibitor |
Mechanisms of action (all sources)
- gamma-secretase inhibitor
Cross-references
Synonyms
- YO-01027
- (S)-2-(2-(3,5-Difluorophenyl)acetamido)-N-((S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl)propanamide
- Deshydroxy LY 411575
- Dibenzazepine (Deshydroxy LY 411575)
- DBZ
- YO01027
- CHEMBL4303400
- gamma-Secretase Inhibitor XX
- YO-01027 (GMP)
- (2S)-2-[[2-(3,5-difluorophenyl)acetyl]amino]-N-[(7S)-5-methyl-6-oxo-7H-benzo[d][1]benzazepin-7-yl]propanamide
- YO-01027 (Dibenzazepine)
- YO-01027 (Dibenzazepine, DBZ)
- C26H23F2N3O3
- Dibenzazepine;DBZ
- YO-01027(Dibenzazepine)
- MLS006011073
- N-[(1S)-2-[[(7S)-6,7-Dihydro-5-methyl-6-oxo-5H-dibenz[b,d]azepin-7-yl]amino]-1-methyl-2-oxoethyl]-3,5-difluorobenzeneacetamide
- Dibenzazepine (YO-01027)
- SCHEMBL3046688
- DTXSID6040458
- EX-A027
- HMS3884B16
- BDBM50533416
- HB3419
- HY-13526G
- MFCD12828734
- s2711
- ZINC22056928
- AKOS016004347
- CCG-264984
- CS-6244
- NCGC00263188-01
- NCGC00263188-03
- AC-27417
- AS-16642
- HY-13526
- SMR004676467
- CS-0622777
- SW219340-1
Look up YO.01027 in the interactive SynDRA portal →